Showing results (101-110 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|February 12, 2024
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular CarcinomaYoung Shin Song, Hannah Yang, Beodeul Kang, et al.
Liver Cancer|February 12, 2024
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular CarcinomaTan-To Cheung, Daniel Wai-Hung Ho, Shirley Xueying Lyu, et al.
Liver Cancer|July 18, 2024
Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection Exhibited Favorable Survival from Immune Checkpoint Inhibitors: A Systematic Review and Meta-AnalysisQi Du, Jia Yuan, Zhenggang Ren
Liver Cancer|September 19, 2024
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter StudyFederico Rossari, Toshifumi Tada, Goki Suda, et al.
Liver Cancer|May 7, 2025
Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150Masatoshi Kudo, Tatsuya Yamashita, Richard S Finn, et al.
Liver Cancer|March 27, 2025
Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular CarcinomaJi Won Han, Min Woo Kang, Soon Kyu Lee, et al.
Liver Cancer|March 27, 2025
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar CarcinomaGhassan K Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, et al.
Liver Cancer|April 21, 2025
Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk StratificationHeechul Nam, Pil Soo Sung, Sung Won Lee, et al.
Liver Cancer|April 21, 2025
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular CarcinomaJiwon Yang, Won-Mook Choi, Hyung-Don Kim, et al.
Liver Cancer|April 17, 2025
18F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver TransplantationWen-Jing Zheng, Yang Xu, Hui Tan, et al.
Pageof 55